Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)

In elderly patients (pts) with aggressive B cell lymphoma (aNHL), curative treatment often cannot be administered because of comorbidities and tolerability. We analyzed the influence of age in pts > 60 years receiving the R-CHOP-14 regimen within different prospective DSHNHL trials. Of the RICOVE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zettl, Florian, Ziepert, Marita, Altmann, Bettina, Zeynalova, Samira, Held, Gerhard, Pöschel, Viola, Hohloch, Karin, Wulf, Gerald G., Glass, Bertram, Schmitz, Norbert, Loeffler, Markus, Trümper, Lorenz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960591/
https://www.ncbi.nlm.nih.gov/pubmed/33242101
http://dx.doi.org/10.1007/s00277-020-04345-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960591/
https://www.ncbi.nlm.nih.gov/pubmed/33242101
http://dx.doi.org/10.1007/s00277-020-04345-3

Ejemplares similares